Close

Letter from Sens. Olympia J. Snowe, Christopher S. Bond, Robert F. Bennett

Nov 4 2003

Comments on FDA's Counterfeit Drug Task Force Interim Report

Nov 3 2003

BIO Letter to the House Leadership supporting passage of H.R. 1561, the United States Patent and Trademark Fee Modernization Act of 2003

Oct 24 2003
On behalf of the Biotechnology Industry Organization (BIO), I urge you to seek prompt passage of H.R. 1561, the United States Patent and Trademark Fee Modernization Act of 2003.

Letter from Sen. Edward Kennedy

Oct 21 2003
To Hector Barreto, Administrator, U.S. Small Business Administration

BIO Comments on FDA's Proposed Rule for Safety Reporting Requirements

Oct 13 2003

Biotech Is More Than Wall St

Sep 25 2003
At the Southern BIO Summit, Dan Eramian

BIO Letter of Support for H.R. 2857, the Pediatric Research Equity Act of 2003

Sep 17 2003

...

Hatch-Waxman Amendments in Senate Bill S. 1 Penalize Biotechnology Companies

Sep 8 2003
Earlier this year both the House and Senate passed their versions of a Medicare reform bill. Included in both the House and Senate bills are virtually identical amendments to the Hatch Waxman law intended to accelerate the entry of generic drugs into the market by closing certain perceived "loopholes" in current law.

Coalition Letter requesting Gov. Davis to veto CA Senate Bill 245

Aug 27 2003
CA Senate Bill 245 would ban transgenic fish in the state.

BIO/MBC testimony opposing Massachusetts House Bill 3565

Aug 27 2003

The bill proposes to establish a food biotechnology task force (Aug. 27, 2003).